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with some national standards of
research rated 3a and 3b. 
A statement released by the
council said, “The overall
improvement in research ratings,
combined with the limited 
amount of funds, means that 
there will inevitably be some
reduction in levels of funding for
departments rated below 5*.”
Newby has estimated that an
extra £200 million a year would
have to be found if departments
were to be funded on the same
basis as before. Total funding for
research for the academic year
2002–2003 has been provisionally
set at £910 million.
Many universities boosted their
rating by omitting up to 20 per
cent of staff from the exercise,
which has led critics to question
the value of the results. And even
top universities face an uncertain
future. Sir Alec Broers, vice
chancellor of Cambridge
University has warned that the
university, like many others, is
going into the red this year, and
the problem would be made more
difficult if the ratings are not fully
rewarded. 
The Association of University
Teachers is pressing the funding
council to protect jobs when
deciding how to allocate the cash.
Sally Hunt, assistant general
secretary of the AUT, wrote to
Newby expressing her concerns.
Many AUT members now fear 
that their work will go unrewarded
because of the need to fund 
the outcome of the 2001 RAE
even more selectively, she says.
“This will have a catastrophic
impact on staff morale and
motivation at a time when our
institutions are already under
intolerable pressure to dance 
to a variety of government 
tunes that are not entirely
harmonious.”
The funding councils will review
the RAE this year to check
whether it is still fit for the
purpose for which it was
designed. “I am sure there will be
another RAE,” says Newby. “I
think it is inevitable that you
reward research on a selective
basis. Whether it is an RAE in the
current form, I have my doubts.”
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A new report on a baffling
disease recognises the key
importance patients and their
carers have in defining features
of the disease and insights into
priorities for research on its
causes. Michael Gross reports.
Just before Christmas, Britain’s
Medical Research Council (MRC)
delivered the detailed review on
the causes and epidemiology of
the baffling condition of autism
and the related autism spectrum
disorders (ASDs, including
Asperger’s syndrome) which the
Department of Health had
commissioned last March 
(Current Biology 11, No.16, R630).
The report breaks ground in
making definitive statements on
issues previously blurred by
controversy and misconceptions,
and thus helps to lay the
foundations for future research
and policy-making.
A major issue is the prevalence
of ASDs. The report concludes
that in children under eight, 6 in
1,000 children are on the autistic
spectrum, confirming that the
condition is not as rare as was
previously thought. The report
withholds judgement on both 
the prevalence in the adult
population and the question of
whether or not there has been 
an increase in recent decades. 
As autism was only defined in 
the 1940s and definitions have
shifted since, comparisons 
over time are still difficult to 
make. 
Considering the causes of
autism, the report reconfirms the
widely held view that the disease
arises from a combination of
many genetic susceptibility
factors, which may be modulated
by environmental influences in
ways which as yet remain
unknown.
In accordance with previous
expert panels, the review confirms
that there is no evidence to
confirm the suspected link
between the MMR vaccine and
ASDs. While the comings and
goings of this possible culprit
have been widely reported in the
media, some more promising
leads such as the prevalence of
bowel disorders in autistic
children, which may point to
physiological links between the
digestive system and
neurotransmitters, have found
little attention so far. 
With respect to the future of
autism research, the report
defines three key areas: 
• improving the case definitions
in order to assist the health
services to the families concerned
as well as research into
epidemiology and causes;
• enhanced epidemiological
studies to clarify the role of
genetic and environmental
factors;
• systematic investigation of
physiological abnormalities linked
to autism. 
Furthermore, the importance of
integration between the different
research disciplines involved,
ranging from clinical psychology
to molecular genetics, and an
improved interfacing with the
professionals in the health
services who are involved in 
the diagnosis and treatment of
autism are highlighted as 
strategic goals. 
Lastly, the report acknowledges
the large amount of knowledge
residing with the ‘lay community’
— people with autism and their
carers. For the first time in a
government-commissioned report
of this magnitude, such common
people participated in all the
meetings and contributed
significantly to the resulting
report. It is to be hoped that this
forebodes an improved
communication and exchange
between all parties interested in
autism, and that a broadly based
research effort will eventually
crack the mystery of this not so
rare disease. 
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